Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease

Sherif M Badawy; Alexis A Thompson; Jin-Shei Lai; Frank J Penedo; Karen Rychlik; Robert I Liem

doi:10.1002/pbc.26369

Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease

Sherif M Badawy^*, Alexis A Thompson, Jin-Shei Lai, Frank J Penedo, Karen Rychlik, Robert I Liem

^*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

43 Scopus citations

Abstract

Background: Complications related to sickle cell disease (SCD) result in significant declines in health-related quality of life (HRQOL). While hydroxyurea reduces SCD complications, adherence remains suboptimal. The study's objectives were to assess the feasibility of Internet-based electronic assessment of HRQOL in SCD clinic and to examine the relationship between HRQOL and hydroxyurea adherence in adolescents and young adults (AYAs) with SCD. Procedure: A cross-sectional survey was administered on tablets to 34 AYAs (12–22 years old) in a SCD clinic from January through December 2015. Study measures included Patient Reported Outcomes Measurement Information System (PROMIS^®) computerized adaptive testing and

Original language	English (US)
Article number	e26369
Journal	Pediatric Blood and Cancer
Volume	64
Issue number	6
DOIs	https://doi.org/10.1002/pbc.26369
State	Published - Jun 1 2017

Keywords

PROMIS
adherence
adolescents
compliance
health-related quality of life
hydroxyurea
patient-reported outcomes
patient-reported outcomes measurement information system
sickle cell anemia
sickle cell disease
young adults

ASJC Scopus subject areas

Pediatrics, Perinatology, and Child Health
Hematology
Oncology

Access to Document

10.1002/pbc.26369

Cite this

@article{12a17772059245388787650108578e84,

title = "Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease",

abstract = "Background: Complications related to sickle cell disease (SCD) result in significant declines in health-related quality of life (HRQOL). While hydroxyurea reduces SCD complications, adherence remains suboptimal. The study's objectives were to assess the feasibility of Internet-based electronic assessment of HRQOL in SCD clinic and to examine the relationship between HRQOL and hydroxyurea adherence in adolescents and young adults (AYAs) with SCD. Procedure: A cross-sectional survey was administered on tablets to 34 AYAs (12–22 years old) in a SCD clinic from January through December 2015. Study measures included Patient Reported Outcomes Measurement Information System (PROMIS{\textregistered}) computerized adaptive testing and",

keywords = "PROMIS, adherence, adolescents, compliance, health-related quality of life, hydroxyurea, patient-reported outcomes, patient-reported outcomes measurement information system, sickle cell anemia, sickle cell disease, young adults",

author = "Badawy, {Sherif M} and Thompson, {Alexis A} and Jin-Shei Lai and Penedo, {Frank J} and Karen Rychlik and Liem, {Robert I}",

year = "2017",

month = jun,

day = "1",

doi = "10.1002/pbc.26369",

language = "English (US)",

volume = "64",

journal = "Medical and Pediatric Oncology",

issn = "1545-5009",

publisher = "Wiley-Liss Inc.",

number = "6",

}

TY - JOUR

T1 - Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease

AU - Badawy, Sherif M

AU - Thompson, Alexis A

AU - Lai, Jin-Shei

AU - Penedo, Frank J

AU - Rychlik, Karen

AU - Liem, Robert I

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Background: Complications related to sickle cell disease (SCD) result in significant declines in health-related quality of life (HRQOL). While hydroxyurea reduces SCD complications, adherence remains suboptimal. The study's objectives were to assess the feasibility of Internet-based electronic assessment of HRQOL in SCD clinic and to examine the relationship between HRQOL and hydroxyurea adherence in adolescents and young adults (AYAs) with SCD. Procedure: A cross-sectional survey was administered on tablets to 34 AYAs (12–22 years old) in a SCD clinic from January through December 2015. Study measures included Patient Reported Outcomes Measurement Information System (PROMIS®) computerized adaptive testing and

AB - Background: Complications related to sickle cell disease (SCD) result in significant declines in health-related quality of life (HRQOL). While hydroxyurea reduces SCD complications, adherence remains suboptimal. The study's objectives were to assess the feasibility of Internet-based electronic assessment of HRQOL in SCD clinic and to examine the relationship between HRQOL and hydroxyurea adherence in adolescents and young adults (AYAs) with SCD. Procedure: A cross-sectional survey was administered on tablets to 34 AYAs (12–22 years old) in a SCD clinic from January through December 2015. Study measures included Patient Reported Outcomes Measurement Information System (PROMIS®) computerized adaptive testing and

KW - PROMIS

KW - adherence

KW - adolescents

KW - compliance

KW - health-related quality of life

KW - hydroxyurea

KW - patient-reported outcomes

KW - patient-reported outcomes measurement information system

KW - sickle cell anemia

KW - sickle cell disease

KW - young adults

UR - http://www.scopus.com/inward/record.url?scp=85006237829&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85006237829&partnerID=8YFLogxK

U2 - 10.1002/pbc.26369

DO - 10.1002/pbc.26369

M3 - Article

C2 - 27896936

AN - SCOPUS:85006237829

VL - 64

JO - Medical and Pediatric Oncology

JF - Medical and Pediatric Oncology

SN - 1545-5009

IS - 6

M1 - e26369

ER -

Health-related quality of life and adherence to hydroxyurea in adolescents and young adults with sickle cell disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this